Multidrug-resistant tuberculosis in Lisbon, Portugal: A molecular epidemiological perspective

Microbial Drug Resistance

Volumn 14, Issue 2, 2008, Pages 133-143

  Perdigão, João ^a   MacEdo, Rita ^b   João, Inês ^b   Fernandes, Elisabete ^b   Brum, Laura ^b   Portugal, Isabel ^a,b  

^a UNIVERSITY OF LISBON   (Portugal)

^b NATIONAL INSTITUTE OF HEALTH DR RICARDO JORGE   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOSALICYLIC ACID; CAPREOMYCIN; CIPROFLOXACIN; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; KANAMYCIN; OFLOXACIN; RIFAMPICIN; STREPTOMYCIN; BACTERIAL PROTEIN; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; BACTERIUM ISOLATE; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; GENE MUTATION; GENOTYPE; HUMAN; INCIDENCE; MOLECULAR EPIDEMIOLOGY; MULTIDRUG RESISTANT TUBERCULOSIS; PORTUGAL; PREVALENCE; PRIORITY JOURNAL; REVIEW; ARTICLE; CLASSIFICATION; CLUSTER ANALYSIS; DRUG EFFECT; EPIDEMIOLOGY; GENETICS; ISOLATION AND PURIFICATION; LUNG TUBERCULOSIS; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MULTIDRUG RESISTANCE; MUTATION; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS; VARIABLE NUMBER OF TANDEM REPEAT;

ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; CLUSTER ANALYSIS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EPIDEMIOLOGY, MOLECULAR; GENOTYPE; HUMANS; MICROBIAL SENSITIVITY TESTS; MINISATELLITE REPEATS; MUTATION; MYCOBACTERIUM TUBERCULOSIS; PORTUGAL; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

EID: 50149104875     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/mdr.2008.0798     Document Type: Review

References (62)

1. Aragón, L.M., F. Navarro, V. Heiser, M. Garrigo, M. Espanol, and P. Coll. 2006. Rapid detection of specific gene mutations associated with isoniazid or rifampicin resistance in Mycobacterium tuberculosis clinical isolates using non-fluorescent low-density DNA microarrays. J. Antimicrob. Chemother. 57:825-831.
2. Barnes, P.F., and M.D. Cave. 2003. Molecular epidemiology of tuberculosis. N. Engl. J. Med. 349:1149-1156.
3. Blackwood, K.S., J.N. Wolfe, and A.M. Kabani. 2004. Application of Mycobacterial Interspersed Repetitive Unit typing to Manitoba tuberculosis cases: can rRestriction Fragment Length Polymorphism be forgotten? J. Clin. Microbiol. 42:5001-5006.
4. Cardoso, R.F., R.C. Cooksey, G.P. Morlock, P. Barco, L. Cecon, F. Forestiero, C.Q. F. Leite, D.N. Sato, M.L. Shikama, and E.M. Mamizuka. 2004. Screening and characterization of mutations in isoniazid-resistant Mycobacterium tuberculosis isolates obtained in Brazil. Antimicrob. Agents Chemother. 48:3373-3381.
5. CDC. 2006. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs worldwide, 2000-2004. Morbid. Mortal. Weekly Rep. 55:301-305.
6. Cheng, S.J., L. Thibert, T. Sanchez, L. Heifets, and Y. Zhang. 2000. pncA mutations as a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis: spread of a monoresistant strain in Quebec, Canada. Antimicrob. Agents Chemother.44:528-532.
7. Coll, P. 2003. Fármacos con actividad frente a Mycobacterium tuberculosis. Enferm. Infecc. Microbiol. Clin. 21:299-308.
8. Coll, P., L.M. Aragon, F. Alcaide, M. Espasa, M. Garrigo, J. Gonzalez, J.M. Manterola, P. Orus, and M. Salvado. 2005. Molecular analysis of isoniazid and rifampin resistance in Mycobacterium tuberculosis isolates recovered from Barcelona. Microb. Drug Resist. 11:107-114.
9. Cooksey, R.C., G.P. Morlock, B.P. Holloway, J. Limor, and M. Hepburn. 2002. Temperature-mediated Heteroduplex analysis performed by using denaturing High-Performance Liquid Chromatography to identify sequence polymorphisms in Mycobacterium tuberculosis complex organisms. J. Clin. Microbiol. 40:1610-1616.
10. Denkin, S., D. Volokhov, V. Chizhikov, and Y. Zhang. 2005. Microarray-based pncA genotyping of pyrazinamide-resistant strains of Mycobacterium tuberculosis. J. Med. Microbiol. 54:1127-1131.
11. DGS. 2004. Programa Nacional de Luta contra a Tuberculose, Ponto da Situação Epidemiológica, Ano de 2003. Direcção Geral de Saúde, Divisão de Doenças Transmissíveis [available at http://www.dgs.pt].
12. DGS. 2005. Programa Nacional de Luta contra a Tuberculose, Ponto da Situação Epidemiológica, Ano de 2004. Direcção Geral de Saúde, Divisão de Doenças Transmissíveis [available at http://www.dgs.pt].
13. EuroTB. 2005. Surveillance of Tuberculosis in Europe, report on Tuberculosis cases notified in 2003. Institut de Veille Sanitaire.
14. Ferech, M., Coenen, S., Malhotra-Kumar, S., Dvorakova, K., Hendrickx, E., Suetens, C., and Goossens, H., on behalf of the ESAC Project Group. 2006. European Surveillance of Antimicrobial Consumption (ESAC): outpatient quinolone use in Europe. J. Antimicrob. Chemother. 58:423-427.
15. Fukuda, M., H. Koga, H. Ohno, B. Yang, Y. Hirakata, S. Maesaki, K. Tomono, T. Tashiro, and S. Kohno. 1999. Relationship between genetic alteration of the rpsL gene and streptomycin susceptibility of Mycobacterium tuberculosis in Japan. J. Antimicrob. Chemother. 43:281-284.
16. Hannan, M.M., E.P. Desmond, G.P. Morlock, G.H. Mazurek, and J. T. Crawford. 2001. Pyrazinamide-monoresistant Mycobacterium tuberculosis in the United States. J. Clin. Microbiol. 39:647-650.
17. Huitric, E., J. Werngren, P. Juréen, and S. Hoffner. 2006. Resistance levels and rpoB gene mutations among in vitro- selected rifampin-resistant Mycobacterium tuberculosis mutants. Antimicrob. Agents Chemother. 50:2860-2862.
18. Johnson, R., A.M. Jordaan, L. Pretorius, E. Engelke, G. van der Spuy, C. Kewley, M. Bosman, P.D. van Helden, R. Warren, and T.C. Victor. 2006. Ethambutol resistance testing by mutation detection. Int. J. Tuberc. Lung Dis. 10:68-73.
19. Jureen, P., L. Engstrand, S. Eriksson, A. Alderborn, M. Krabbe, and S.E. Hoffner. 2006. Rapid detection of rifampin resistance in Mycobacterium tuberculosis by pyrosequencing technology. J. Clin. Microbiol. 44:1925-1929.
20. Kapur, V., L.L. Li, S. Iordanescu, M.R. Hamrick, A. Wanger, B.N. Kreiswirth, and J.M. Musser. 1994. Characterization by automated DNA sequencing of mutations in the gene (rpoB) encoding the RNA polymerase beta subunit in rifampin-resistant Mycobacterium tuberculosis strains from New York City and Texas. J. Clin. Microbiol. 32:1095-1098.
21. Kirschner, P., and E.C. Bottger. 1996. Detection of mycobacterium resistance to streptomycin and clarithromycin. PCR protocols for emerging infectious diseases. ASM Press, Washington, DC, pp. 130-137.
22. Larsen, M.H., C. Vilcheze, L. Kremer, G.S. Besra, L. Parsons, M. Salfinger, L. Heifets, M.H. Hazbon, D. Alland, J.C. Sacchettini, and W.R. Jacobs Jr. 2002. Overexpression of inhA, but not kasA, confers resistance to isoniazid and ethionamide in Mycobacterium smegmatis, M. bovis BCG and M. tuberculosis. Mol. Microbiol. 46:453-466.
23. Lee, A.S.G., I.H.K. Lim, L.L.H. Tang, A. Telenti, and S.Y. Wong. 1999. Contribution of kasA analysis to detection of isoniazid-resistant Mycobacterium tuberculosis in Singapore. Antimicrob. Agents Chemother. 43:2087-2089.
24. Lemaitre, N., W. Sougakoff, C. Truffot-Pernot, and V. Jarlier. 1999. Characterization of new mutations in pyrazinamide-resistant strains of Mycobacterium tuberculosis and identification of conserved regions important for the catalytic activity of the pyrazinamidase pncA. Antimicrob. Agents Chemother. 43:1761-1763.
25. Ma, X., H. Wang, Y. Deng, Z. Liu, Y. Xu, X. Pan, J.M. Musser, and E. A. Graviss. 2006. rpoB Gene mutations and molecular characterization of rifampin-resistant Mycobacterium tuberculosis isolates from Shandong Province, China. J. Clin. Microbiol. 44:3409-3412.
26. Manissero, D., Fernandez de la Hoz, K. 2006. Surveillance methods and case definition for extensively drug resistant TB (XDR-TB) and relevance to Europe: summary update. European Centre for Disease Prevention and Control.
27. Masjedi, M.R., P. Farnia, S. Sorooch, M.V. Pooramiri, S.D. Mansoori, A.Z. Zarifi, A. Akbarvelayati, and S. Hoffner. 2006. Extensively drug-resistant tuberculosis: 2 years of surveillance in Iran. Clin. Infect. Dis. 43:841-847.
28. Meier, A., P. Kirschner, F.C. Bange, U. Vogel, and E.C. Bottger. 1994. Genetic alterations in streptomycin-resistant Mycobacterium tuberculosis: mapping of mutations conferring resistance. Antimicrob. Agents Chemother. 38:228-233.
29. Meier, A., P. Sander, K.J. Schaper, M. Scholz, and E.C. Bottger. 1996. Correlation of molecular resistance mechanisms and phenotypic resistance levels in streptomycin-resistant Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 40:2452-2454.
30. Mestdagh, M., P.A. Fonteyne, L. Realini, R. Rossau, G. Jannes, W. Mijs, K.A.L. De Smet, F. Portaels, and E. Van den Eeckhout. 1999. Relationship between pyrazinamide resistance, loss of pyrazinamidase activity, and mutations in the pncA locus in multidrug-resistant clinical isolates of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 43: 2317-2319.
31. Mieskes, K.T., S. Rusch-Gerdes, C. Truffot-Pernot, K. Feldmann, E. Tortoli, M. Casal, T. Loscher, and H. Rinder. 2000. Rapid, simple, and culture-independent detection of rpsL codon 43 mutations that are highly predictive of streptomycin resistance in Mycobacterium tuberculosis. Am. J. Trop. Med. Hyg. 63:56-60.
32. Morlock, G.P., J.T. Crawford, W.R. Butler, S.E. Brim, D. Sikes, G.H. Mazurek, C.L. Woodley, and R.C. Cooksey. 2000. Phenotypic characterization of pncA mutants of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 44:2291-2295.
33. Narayanan, S. 2004. Molecular epidemiology of tuberculosis. Indian J. Med. Res. 120:233-247.
34. Nikolayevsky, V., T. Brown, Y. Balabanova, M. Ruddy, I. Fedorin, and F. Drobniewski. 2004. Detection of mutations associated with isoniazid and rifampin resistance in Mycobacterium tuberculosis isolates from Samara region, Russian Federation. J. Clin. Microbiol. 42:4498-4502.
35. Parsons, L.M., M. Salfinger, A. Clobridge, J. Dormandy, L. Mirabello, V.L. Polletta, A. Sanic, O. Sinyavskiy, S.C. Larsen, and J. Driscoll. 2005. Phenotypic and molecular characterization of Mycobacterium tuberculosis isolates resistant to both isoniazid and ethambutol. Antimicrob. Agents Chemother. 49:2218-2225.
36. Pfyffer, G., D. Bonato, A. Ebrhimzadeh, W. Gross, J. Hotaling, J. Kornblum, A. Laszlo, G. Roberts, M. Salfinger, F. Wittwer, and S. Siddiqi. 1999. Multicenter laboratory validation of susceptibility testing of Mycobacterium tuberculosis against classical second-line and newer antimicrobial drugs by using the radiometric BACTEC 460 technique and the proportion method with solid media. J. Clin. Microbiol. 37:3179-3186.
37. Plinke, C., S. Rusch-Gerdes, and S. Niemann. 2006. Significance of mutations in embB codon 306 for prediction of ethambutol resistance in clinical Mycobacterium tuberculosis isolates. Antimicrob. Agents Chemother. 50:1900-1902.
38. Portugal, I., L. Barreiro, J. Moniz-Pereira, and L. Brum. 2004. pncA Mutations in pyrazinamide-resistant Mycobacterium tuberculosis isolates in Portugal. Antimicrob. Agents Chemother. 48:2736-2738.
39. Portugal, I., M.J. Covas, L. Brum, M. Viveiros, P. Ferrinho, J. Moniz-Pereira, and H. David. 1999. Outbreak of multiple drug-resistant tuberculosis in Lisbon: detection by restriction fragment length polymorphism analysis. Int. J. Tuberc. Lung Dis. 3:207-213.
40. Portugal, I., S. Maia, and J. Moniz-Pereira. 1999. Discrimination of multidrug-resistant Mycobacterium tuberculosis IS6110 fingerprint subclusters by rpoB gene mutation analysis. J. Clin. Microbiol. 37:3022-3024.
41. Ramaswamy, S., and J.M. Musser. 1998. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuberc. Lung Dis. 79:3-29.
42. Ramaswamy, S.V., A.G. Amin, S. Göksel, C.E. Stager, S.J. Dou, H. El Sahly, S.L. Moghazeh, B.N. Kreiswirth, and J.M. Musser. 2000. Molecular genetic analysis of nucleotide polymorphisms associated with ethambutol resistance in human isolates of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 44:326-336.
43. Rindi, L., L. Bianchi, E. Tortoli, N. Lari, D. Bonanni, and C. Garzelli. 2005. Mutations responsible for Mycobacterium tuberculosis isoniazid resistance in Italy. Int. J. Tuberc. Lung Dis. 9:94-97.
44. Rodrigues, V. F.S., M.A. Telles, M.O. Ribeiro, P.I. Cafrune, M.L.R. Rossetti, and A. Zaha. 2005. Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis in Brazil. Antimicrob. Agents Chemother. 49: 444-446.
45. Sajduda, A., A. Brzostek, M. Poplawska, E. Augustynowicz-Kopec, Z. Zwolska, S. Niemann, J. Dziadek, and D. Hillemann. 2003. Molecular characterization of rifampin and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Poland. J. Clin. Microbiol. 42:2425-2431.
46. Scorpio, A., P. Lindholm-Levy, L. Heifets, R. Gilman, S. Siddiqi, M. Cynamon, and Y. Zhang. 1997. Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 41:540-543.
47. Scorpio, A., and Y. Zhang. 1996. Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus. Nat. Med. 2:662-667.
48. Silva, M.S.N., S.G. Senna, M.O. Ribeiro, A.R.M. Valim, M.A. Telles, A. Kritski, G.P. Morlock, R.C. Cooksey, A. Zaha, and M.L.R. Rossetti. 2003. Mutations in katG, inhA, and ahpC genes of Brazilian isoniazid-resistant isolates of Mycobacterium tuberculosis. J. Clin. Microbiol. 41: 4471-4474.
49. Somoskovi, A., L.M. Parsons, and M. Salfinger. 2001. The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis. Respir. Res. 2:164-168.
50. Sreevatsan, S., X. Pan, K.E. Stockbauer, D.L. Williams, B.N. Kreiswirth, and J.M. Musser. 1996. Characterization of rpsL and rrs mutations in streptomycin-resistant Mycobacterium tuberculosis isolates from diverse geographic localities. Antimicrob. Agents Chemother. 40:1024-1026.
51. Supply, P., C. Allix, S. Lesjean, M. Cardoso-Oelemann, S. Rusch-Gerdes, E. Willery, E. Savine, P. de Haas, H. van Deutekom, and S. Roring. 2006. Proposal for standardization of optimized Mycobacterial Interspersed Repetitive Unit-Variable Number Tandem Repeat typing of Mycobacterium tuberculosis. J. Clin. Microbiol. 44:4498-4510.
52. Supply, P., S. Lesjean, E. Savine, K. Kremer, D. van Soolingen, and C. Locht. 2001. Automated high-throughput genotyping for study of global epidemiology of Mycobacterium tuberculosis based on Mycobacterial Interspersed Repetitive Units. J. Clin. Microbiol. 39:3563-3571.
53. Uhl, J.R., G.S. Sandhu, B.C. Kline, and F.R. Cockerill III. 1996. PCR-RFLP detection of point mutations in the catalase-peroxidase gene (katG) of Mycobacterium tuberculosis associated with isoniazid resistance. PCR protocols for emerging infectious disease. ASM Press, Washington, DC, pp. 144-149.
54. Van Rie, A., R. Warren, I. Mshanga, A.M. Jordaan, G.D. van der Spuy, M. Richardson, J. Simpson, R.P. Gie, D.A. Enarson, and N. Beyers. 2001. Analysis for a limited number of gene codons can predict drug resistance of Mycobacterium tuberculosis in a high-incidence community. J. Clin. Microbiol. 39:636-641.
55. Van Soolingen, D., P.E.W. de Haas, and K. Kremer. 2002. Restriction fragment length polymorphism (RFLP) typing of mycobacteria. National Institute of Public Health and The Environment, Bilthoven, The Netherlands.
56. Van Soolingen, D., P.W. Hermans, P.E. de Haas, D.R. Soll, and J.D. van Embden. 1991. Occurrence and stability of insertion sequences in Mycobacterium tuberculosis complex strains: evaluation of an insertion sequence-dependent DNA polymorphism as a tool in the epidemiology of tuberculosis. J. Clin. Microbiol. 29:2578-2586.
57. Vilchèze, C., F. Wang, M. Arai, M.H. Hazbón, R. Colangeli, L. Kremer, T.R. Weisbrod, D. Alland, J.C. Sacchettini, and W.R. Jacobs Jr. 2006. Transfer of a point mutation in Mycobacterium tuberculosis inhA resolves the target of isoniazid. Nat. Med. 12:1027-1029.
58. Vilcheze, C., T.R. Weisbrod, B. Chen, L. Kremer, M.H. Hazbon, F. Wang, D. Alland, J.C. Sacchettini, and W.R. Jacobs. 2005. Altered NADH/NAD + ratio mediates coresistance to isoniazid and ethionamide in mycobacteria. Antimicrob. Agents Chemother. 49:708-720.
59. Warren, R., M. Richardson, S. Sampson, J.H. Hauman, N. Beyers, P.R. Donald, and P.D. van Helden. 1996. Genotyping of Mycobacterium tuberculosis with additional markers enhances accuracy in epidemiological studies. J. Clin. Microbiol. 34:2219-2224.
60. WHO. 2006. Extensive drug-resistant tuberculosis (XDR-TB): recommendations for prevention and control. Weekly Epidemiol. Rec. 81:430-432.
61. Williams, D.L., C. Waguespack, K. Eisenach, J.T. Crawford, F. Portaels, M. Salfinger, C.M. Nolan, C. Abe, V. Sticht-Groh, and T.P. Gillis. 1994. Characterization of rifampin-resistance in pathogenic mycobacteria. Antimicrob. Agents Chemother. 38:2380-2386.
62. Zhang, M., J. Yue, Y. Yang, H. Zhang, J. Lei, R. Jin, X. Zhang, and H. Wang. 2005. Detection of mutations associated with isoniazid resistance in Mycobacterium tuberculosis isolates from China. J. Clin. Microbiol. 43:5477-5482.